References
- Haskell, M.C. and Rosen, L. (2001) "Antineoplastic agents", In: Haskell, M.C. and Berek, J.S., eds, Cancer Treatment, 5th Ed., pp. 149–151.
- Ng, H.J. and Lim, L.C. (2001) "Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report", Ann. Hematol. 80(9), 549–552.
- Yeo, W., Chan, P.K., Thong, S. et al. (2000) "Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors (abstract)", J. Med. Virol. 62(3), 299–307.
- Xunrong, L., Yan, A.W., Liang, R. and Lau, G.K. (2001) "Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy—pathogenesis and management", Rev. Med. Virol. 11(5), 287–299.
- Yeo, W., Steinberg, J.L., Tam, J.S. et al. (1999) "Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy", J. Med. Virol. 59(3), 263–269.
- Yeo, W., Chan, P.K., Chan, H.L. et al. (2001) "Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replica-tion precedes overt hepatitis", J. Med. Virol. 65(3), 473–477.
- Liao, C.A., Lee, C.M., Wu, H.C. et al. (2002) "Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma", Br J. Haematol. 116(1), 166–169.
- Persico, M., De Marino, F., Russo, G.D. et al. (2002) "Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma", Blood 99(2), 724–725.
- Stroffolini, T., Andriani, A., Bibas, M. and Barlattani, A. (2002) "Successful treatment with lamivudine for reactivated hepatitis B infection following chemotherapy for non-Hodgkin's lymphoma", Ann. Hematol. 81(1), 48–49.
- Endo, T., Sakai, T., Fujimoto, K. et al. (2001) "A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma", Bone Marrow Transplant. 27(4), 433–436.
- Ahmed, A. and Keefee, E.B. (1999) "Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection", Am. J. Gastroenterol. 94(1), 249–251.
- Al-Taie, OH., Mork, H., Gassel, A.M. et al. (1999) "Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature", Ann. Hematol. 78(5), 247–249.
- Ishiga, K., Kawatani, T., Suou, T. et al. (2001) "Fulminant hepatitis type B after chemotherapy in a serologically negative B virus carrier with acute myelogenous leukemia", Int. J. Hematol. 73(1), 115–118.